:: CLDF ::

1.	Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease.
	Wan, Xia (X);Xu, Hua (H);Li, Hu (H);Zhong, Shan (S);Lei, Yu (Y);Deng, Huan (H);Fu, Xiao (X);Zhou, Zhi (Z);

Predictors for Publication of Specialty Theses in the Field of Infectious Diseases and Clinical Microbiology.

?rkören, Pelin (P);Agülo?lu-Bali, Elif (E);Usta, O?uz (O);?enol, Arzu (A);Manavl?, Bar?? (B);Tan?r, Bü?ra (B);Gürbüz, Esra (E);Araz, Halime (H);Al?ravc?, I??l Deniz (ID);Can, ?lkay Nur (?N);Demir-Önder, Kübra (K);Co?kunp?nar-Törüyenler, Melike (M);Deniz, Mustafa (M);Boran, Riyad (R);M?zrakç?, Serpil (S);Ak?l, ?ükran Sevim (?S);Pala-Karakök, Taliha (T);Tüzün, Türkam (T);Çak?r-K?ymaz, Yasemin (Y);Ürkmez-Korkmaz, Fatma Yekta (FY);Uygun-K?zmaz, Ye?im (Y);Özger, Selçuk (S);Ergönül, Önder (Ö);

3.	Clinical Value of Metagenomic Next-Generation Sequencing From Blood Samples to Identify Pneumonia in Patients With Human Immunodeficiency Virus.
	Luo, Hongyu (H);Jiang, Yongfang (Y);He, Yan (Y);Zhou, Huaying (H);

Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study

Viruses.?2025 Feb 12;17(2):251.?doi: 10.3390/v17020251.

Luca Rinaldi?1,?Mauro Viganò?2,?Alessia Ciancio?3,?Alfredo Caturano?4?5,?Vincenzo Messina?6,?Grazia Anna Niro?7,?Nicolina Capoluongo?8,?Alessandro Loglio?2,?Letizia Marinaro?3,?Aldo Marrone?4,?Ernesto Claar?9,?Maurizio Russello?10,?Emanuela Ciracì?11,?Umberto Vespasiani Gentilucci?12,?Valeria Pace Palitti?13,?Carlo Acierno?14,?Clelia Cosentino?4,?Andrea Mormone?4,?Rosa Cotugno?7,?Francesca Terracciani?12,?Paolo Gallo?12,?Maria Rita Cannavò?10,?Valerio Rosato?9,?Ferdinando Carlo Sasso?4,?Chiara Petrucciello?1,?Giulio Petronio Petronio?1,?Giovanni Villone?1,?Francesco Benanti?15,?Giuseppe Cariti?3,?Elisabetta Falbo?16,?Marco Distefano?17,?Rodolfo Sacco?18,?Alessandro Perrella?8,?Antonio Izzi?8

Current and future therapeutic options for chronic hepatitis D virus infection

FrontCellInfectMicrobiol.?2025Feb11:14:1382017.doi:10.3389/fcimb.2024.1382017.?eCollection 2024.

Mariantonietta Pisaturo?1,?Antonio Russo?1,?Pierantonio Grimaldi?1,?Salvatore Martini?1,?Nicola Coppola?1

Clinical Pharmacology of Bulevirtide: Focus on Known and Potential Drug-Drug Interactions

Pharmaceutics.?2025 Feb 14;17(2):250.?doi: 10.3390/pharmaceutics17020250.

Martina Billi?1,?Sara Soloperto?1,?Stefano Bonora?1,?Antonio D'Avolio?1,?Amedeo De Nicolò?1

7.	The synthetic opioid fentanyl increases HIV replication in macrophages.
	Madhuravasal Krishnan, Janani (J);Kong, Ling (L);Meeds, Heidi L (HL);Roskin, Krishna M (KM);Medvedovic, Mario (M);Sherman, Kenneth E (KE);Blackard, Jason T (JT);

8.	Reaching priority populations with different HIV self-testing distribution models in South Africa: an analysis of programme data.
	Majam, Mohammed (M);Hatzold, Karin (K);Mavhu, Webster (W);Tembo, Angela (A);Zishiri, Vincent (V);Phiri, Jane (J);Conserve, Donaldson (D);Haile, Zelalem (Z);Chidarikire, Thato (T);Johnson, Cheryl C (CC);Moyo, Sangiwe (S);Meyer-Rath, Gesine (G);Venter, Francois (F);

9.	Enhancing HIV self-testing uptake among university students in Rwanda: the proportion, barriers, and opportunities.
	Mukashyaka, Ritah (R);Kaberuka, Gerald (G);Favina, Alain (A);Lutasingwa, Dan (D);Mulisa, Fred (F);Turatsinze, Everest (E);Karanja, Ann (A);Kansiime, Deborah (D);Niyotwagira, Egide (E);Ikuzo, Basile (B);Kaggwa, Mark Mohan (MM);Kagaba, Aflodis (A);Mathebula, Evans Mantiri (EM);Rwibasira, Gallican N (GN);

10.	Using nominal group technique to identify and prioritize barriers to decentralizing HIV care to primary health centers in Lima, Peru.
	Oliveros, David (D);Konda, Kelika A (KA);Madden, Lynn M (LM);Montenegro-Idrogo, Juan José (JJ);Tafur Quintanilla, Karla T (KT);Sosa Barbarán, Karin (K);Nikitin, Benjamin M (BM);Ponticiello, Matthew (M);Benites, Carlos M (CM);Sánchez, Jorge (J);Altice, Frederick L (FL);

11.

Bulevirtide in Chronic Hepatitis D Patients Awaiting Liver Transplantation Results From a French Multicentric Retrospective Study

Liver Int.?2025 Mar;45(3):e70033.?doi: 10.1111/liv.70033.

Magdalena Meszaros?1,?Marie-Noëlle Hilleret?2,?Jérôme Dumortier?3,?Louis D'Alteroche?4,?Armand Abergel?5,?Marianne Latournerie?6,?Teresa Antonini?7,?Filomena Conti?8,?Patrick Borentain?9,?Sébastien Dharancy?10,?Georges-Philippe Pageaux?1?11

12.	HIV retesting prevalence among clients accessing anti-retroviral therapy and HIV testing services in Ghana.
	Adu-Gyamfi, Raphael (R);Addo, Stephen Ayisi (SA);Baddoo, Nyonuku Akosua (NA);Kenu, Ernest (E);Ashinyo, Anthony (A);Owusu, Kwadwo Koduah (KK);Chihana, Menard Laurent (ML);Adams, Alice Sallar (AS);Magdalene, Odikro (O);Bandoh, Delia (D);Abdulai, Marijanatu (M);Danso, Kenneth (K);Senya, Kafui (K);Johnson, Cheryl (C);

13.

A US-Based Multi-Site Pilot to Screen Hepatitis B Surface Antigen-Positive Patients for Hepatitis D

J Viral Hepat.?2025 Jan;32(1):e14043.?doi: 10.1111/jvh.14043.

Maggie Li?1?2,?Bijou Hunt?1,?Bindu Balani?3,?Chinwe Ogedegbe?4,?Peter Gordon?5,?Joshua Hayden?6,?Nancy Glick?1,?Anita Chang?7,?Su Wang?8,?Mitchell Caponi?9,?Lisa Yarber-Cambron?6,?Sandeep Bhat?9,?Tyshea Ward?10,?Madhu Suryadevara?10

14.

HDV RNA assays: Performance characteristics, clinical utility, and challenges

Hepatology.?2025 Feb 1;81(2):637-650.?doi: 10.1097/HEP.0000000000000584.Epub 2023 Aug 28.

Heiner Wedemeyer?1?2?3?4,?Mitchell Leus?5,?Thomas R Battersby?6,?Jeffrey Glenn?7,?Emmanuel Gordien?8,?Saleem Kamili?9,?Hema Kapoor?10,?Harald H Kessler?11,?Oliver Lenz?12,?Marc Lütgehetmann?13?14,?Tonya Mixson-Hayden?9,?Christian O Simon?15,?Michael Thomson?16,?Gabriel Westman?17?18,?Veronica Miller?5,?Norah Terrault?19,?Pietro Lampertico?20?21;?HDV RNA Assays Writing Group at the HBV Forum

15.

J Viral Hepat.?2025 Feb;32(2):1-15.?doi: 10.1111/jvh.14060.

Arno Furquim d'Almeida?1?2,?Erwin Ho?2,?Liesbeth Govaerts?2,?Peter Michielsen?2,?Thomas Sersté?3,?Stefan Bourgeois?4,?Jean Delwaide?5,?Christophe Moreno?6,?Hans Orlent?7,?Hans Van Vlierberghe?8,?Chantal de Galocsy?9,?Michael Peeters?10,?Elizaveta Padalko?11,?Steven Van Gucht?10,?Thomas Vanwolleghem?1?2

16.

Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection

Liver Int.?2025 Feb;45(2):e70003.?doi: 10.1111/liv.70003.

Lisa Sandmann?1?2?3,?Valerie Ohlendorf?1,?Alena Ehrenbauer?1,?Birgit Bremer?1,?Anke R M Kraft?1?3?4?5,?Markus Cornberg?1?2?3?4?5,?Katja Deterding?1,?Heiner Wedemeyer?1?2?3?4,?Benjamin Maasoumy?1?4

17.

Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting

Aliment Pharmacol Ther.?2025 Feb;61(4):651-657.?doi: 10.1111/apt.18424.?Epub 2024 Dec 4.

Toni Herta?1?2?3,?Anna Joachim-Richter?4,?David Petroff?5,?Benno Wölk?4,?Ingmar Wolffram?6,?Thomas Berg?1,?Jan Kramer?4,?Olaf Bätz?4,?Johannes Wiegand?1

18.

Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNa-2a as Treatment for Chronic Hepatitis Delta

Liver Int.?2025 Feb;45(2):e70008.?doi: 10.1111/liv.70008.

Pietro Lampertico?1?2,?Pavel O Bogomolov?3,?Vladimir Chulanov?4?5,?Tatiana Stepanova?6,?Viacheslav Morozov?7,?Lena Allweiss?8?9,?Maura Dandri?8?9,?Jürgen Burhenne?10?11,?Antje Blank?10?11,?Sandra Ciesek?12?13,?Carina Elsner?14,?Ulf Dittmer?14,?Qi An?15,?Dmitry Manuilov?15,?Ben L Da?15,?John F Flaherty?15,?Stephan Urban?11?16,?Heiner Wedemeyer?17?18?19

19.	Two dramatically different clinical scenarios of neonatal Echovirus-11 infection in late preterm male twins: a case report and review of the literature.
	Perniciaro, Simona (S);Proietti, Caterina (C);Bossi, Angela (A);Maragliano, Roberta (R);Facco, Carla (C);Novazzi, Federica (F);Mancini, Nicasio (N);Agosti, Massimo Agostino (MA);

20.

Characterizing Hepatitis Delta in Spain and the gaps in its management

Gastroenterol Hepatol.?2025 Feb;48(2):502222.doi: 10.1016/j.gastrohep.2024.502222.?Epub 2024 Jun 20.

Sergio Rodríguez-Tajes?1,?Adriana Palom?2,?Álvaro Giráldez-Gallego?3,?Antonio Moreno?3,?Juan José Urquijo?4,?Manuel Rodríguez?5,?Marta Alvarez-Argüelles?5,?Moisés Diago?4,?María García-Eliz?6,?Javier Fuentes?7,?Ana María Martínez-Sapiña?7,?Pilar Castillo?8,?Marta Casado?9,?Elena Pérez-Campos?9,?Raquel Muñoz?10,?Marta Hernández-Conde?11,?Rosa María Morillas?12,?Rafael Granados?13,?Mireia Miquel?14,?María Julia Morillas?15,?Monserrat García-Retortillo?16,?Jose Antonio Carrión?16,?José María Moreno?17,?Cristina Montón?18,?Jesús Manuel González-Santiago?19,?Sara Lorente?20,?Joaquín Cabezas?21,?Beatriz Mateos?22,?Sergio Vázquez-Rodríguez?23,?Fernando Díaz-Fontenla?24,?José María Pinazo?25,?Mercè Delgado?26,?Domingo Pérez-Palacios?27,?Diana Horta?28,?Cristina Fernández-Marcos?29,?Carmen López?30,?José Luis Calleja?11,?Inmaculada Fernández?10,?Javier García-Samaniego?8,?Xavier Forns?1,?María Buti?2,?Sabela Lens?31

21.	Effect of FLT3 ligand on the gene expression of TIM-3, HIF1-?, and TNF-? in an acute myeloid leukemia cell line.
	Heidari, Fatemeh (F);Kazemi-Sefat, Nazanin Atieh (NA);Feizollahi, Parisa (P);Gerdabi, Sajjad (S);Pourfathollah, Ali Akbar (AA);Ebtekar, Masoumeh (M);

22.	Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer.
	Wang, XinJian (X);You, Hang (H);Zhang, Teng (T);Li, Yuan (Y);Chen, XinYu (X);Basler, Michael (M);Jiang, QingMing (Q);Chen, Han (H);Liu, Nan (N);Yuan, Fang (F);Li, Jun (J);

23.	Hepatotoxicity From Disease-Modifying Anti-rheumatic Drugs (DMARDs) and Association With Metabolic Syndrome in Rheumatoid Arthritis.
	Nandan, Abhishek (A);Haritha, Josna (J);Maniscalco, David (D);Gill, Rabia (R);Puri, Puneet (P);Rodriguez, Viviana (V);Syed, Huzaefah (H);

24.	Level of adherence to physical activity recommendations among adults with type 2 diabetes in Qatar and associated factors: a cross-sectional study.
	Boutefnouchet, Linda (L);Hoque, Bushra (B);Sukik, Layan (L);Rahhal, Mhd Osama (MO);Elhadary, Mohamed (M);Hamdan, Ahmad (A);Altrmanini, Omar (O);Abuhaweeleh, Mohannad Natheef (MN);Bawadi, Hiba (H);Shraim, Mujahed (M);

25.

TIGIT-expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis D

Hepatology. 2025 Jan 23. doi: 10.1097/HEP.0000000000001238. Online ahead of print.

Po-Chun Chen¹², Katja Deterding¹, Sophie Anna Engelskircher¹, Kerstin Port¹, Lisa Sandmann¹³⁴, Athira Chakkadath¹², Tijana Ristic¹, Qingyu Wu¹, Birgit Bremer¹, Anke R M Kraft¹⁵⁶, Markus Cornberg¹³⁴⁵⁶, Albert Heim⁷, Helenie Kefalakes¹⁴, Niklas K Björkström⁸, Norman Woller¹⁵, Heiner Wedemeyer¹³⁴⁵

Subscribe